ArticleLife (Basel, Switzerland)2025

Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis.

Giuseppe Annunziata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.